With regular maintenance sessions and consistent sun protection, most patients maintain noticeable improvement for 612 months or longer
Theres no single right answerwhat matters is having a plan that accounts for how your appetite and weight tend to respond when the medication changes
But consider the cost of: Ongoing health conditions related to excess weight Medications for blood pressure, cholesterol, or diabetes Lost productivity and quality of life Previous diet programs that didnt work For many patients, Semaglutide pays for itself in reduced healthcare costs and improved wellbeing
Meanwhile, Chinese companies are rapidly advancing through fast following, innovation and licensing, with key developments including Innovents mazdutide, Innogens supaglutide, Hengruis oral candidate HRS-7535, United Laboratories licensing of its first-in-class triple-G (GLP-1, gastric inhibitory polypeptide (GIP) and glucagon) a gonist to Novo Nordisk and Ascletis positive Phase 1 results for its oral + injection candidate, ASC30
this can cause nausea, bloating, and prolonged fullness, particularly during dose escalation
Look for trends rather than one-off numbers